B-MS hooks up with Celgene to test cancer combo

Posted: August 20th, 2014  |  Company/topic: Celgene
Website:
B-MS hooks up with Celgene to test cancer combo…

Celgene’s cost-sharing offer persuades NICE to about-face on Revlimid

Posted: August 20th, 2014  |  Company/topic: Celgene
Website:
Celgene used a tried-and-true technique to persuade cost-effectiveness watchdogs to change their minds on Revlimid. The U.S.-based drugmaker capped its cost.

UK cost effectiveness agency gives support to Celgene bone marrow drug

Posted: August 20th, 2014  |  Company/topic: Celgene
Website:
LONDON (Reuters) - Celgene's drug Revlimid should be an option on Britain's state health service for patients with serious bone marrow disorders and a specific chromosomal abnormality, the country's c…

UK cost agency backs Celgene bone marrow drug in change of tack

Posted: August 19th, 2014  |  Company/topic: Celgene
Website:
LONDON (Reuters) - Celgene's drug Revlimid should be an option on Britain's state health service for patients with serious bone marrow disorders and a specific chromosomal abnormality, the country's c…